The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Humana Inc

NYSE: HUM
Last

(U.S.) $146.47

Today's change-2.60 -1.74%
Updated December 19 4:08 PM EST. Delayed by at least 15 minutes.
 

Humana Inc

NYSE: HUM
Last

(U.S.) $146.47

Today's change-2.60 -1.74%
Updated December 19 4:08 PM EST. Delayed by at least 15 minutes.

Sharp drop following new 52-week high

Humana Inc closed sharply lower Friday, dropping (U.S.)$2.60 or 1.74% to (U.S.)$146.47 after setting a new 52-week high. Over the last five days, shares have gained 2.00% and are currently 3.33% off of the 52-week high. Shares have outperformed the S&P 500 by 29.61% during the last year.

Key company metrics

  • Open(U.S.) $149.84
  • Previous close(U.S.) $149.07
  • High(U.S.) $151.52
  • Low(U.S.) $146.42
  • Bid / Ask-- / --
  • YTD % change+41.90%
  • Volume2,099,689
  • Average volume (10-day)1,251,315
  • Average volume (1-month)1,241,163
  • Average volume (3-month)1,264,528
  • 52-week range(U.S.) $91.00 to (U.S.) $151.52
  • Beta0.65
  • Trailing P/E23.60×
  • P/E 1 year forward19.30×
  • Forward PEG2.17×
  • Indicated annual dividend(U.S.) $1.12
  • Dividend yield0.76%
  • Trailing EPS(U.S.) $6.21
Updated December 19 4:08 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue12,23812,22211,71210,187
Total other revenue--------
Total revenue12,23812,22211,71210,187
Gross profit--------
Total cost of revenue--------
Total operating expense11,64911,54110,99110,201
Selling / general / administrative--------
Research & development--------
Depreciation / amortization85798290
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total11,56411,46210,90910,111
Operating income589681721-14
Interest income (expense), net non-operating-38-35-35-35
Gain (loss) on sale of assets--------
Other--------
Income before tax551646686-49
Income after tax290344368-30
Income tax, total261302318-19
Net income290344368-30
Total adjustments to net income--------
Net income before extra. items290344368-30
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items290344368-30
Inc. avail. to common incl. extra. items290344368-30
Diluted net income290344368-30
Dilution adjustment------0
Diluted weighted average shares156157157158
Diluted EPS excluding extraordinary itemsvalue per share1.862.192.35-0.19
Dividends per sharevalue per share0.280.270.270.26
Diluted normalized EPSvalue per share1.862.192.35-0.19